Judi Health vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Formerly Capital Rx; $607M raised total, $3.25B valuation (Sep 2025); AI-powered PBM + unified health benefits platform; $3.7B revenue run-rate; 4M+ employer PBM members; 54M+ health plan lives.
About
Judi Health (formerly Capital Rx) is a New York-based healthcare technology company that provides transparent pharmacy benefit management (PBM) and unified health benefits administration. Founded in 2017 by CEO AJ Loiacono and CTO Ryan Kelly, the company was built to disrupt the traditionally opaque PBM industry by offering a flat-fee, aligned pricing model that eliminates the hidden rebate economics that drive up drug costs for employers and health plans. In September 2025, Capital Rx rebranded as Judi Health to reflect its expansion beyond pharmacy into comprehensive health benefits.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.